Quintiles prices secondary public offering of 15M shares of common stock

Quintiles today announced the pricing of a secondary public offering of 15 million shares of its common stock by certain of its shareholders at a price to the public of $52.00 per share. In addition, the selling shareholders have granted the underwriters a 30-day option to purchase up to an additional 2.25 million shares of common stock. The offering is expected to close on March 18, 2014, subject to customary closing conditions.

Quintiles is not selling any shares in this offering and will not receive any proceeds from the sale of the shares by the selling shareholders.

Morgan Stanley, Barclays and J.P. Morgan are serving as joint book-running managers and as representatives of the underwriters for the offering. Citigroup, Goldman, Sachs & Co., Wells Fargo Securities, BofA Merrill Lynch and Deutsche Bank Securities are serving as book-running managers for the offering. Baird, William Blair and Jefferies are serving as lead co-managers, and Guggenheim Securities, Piper Jaffray, Raymond James, RBC Capital Markets and UBS Investment Bank are serving as co-managers for the offering.



Posted in: Business / Finance

Tags: , ,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
You might also like... ×
Quintiles announces agreements to expand lab testing capabilities in China